What Is DSIP? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. DSIP is not FDA-approved for insomnia, sleep quality, stress, pain, addiction, anti-aging, recovery, or any therapeutic use. Products sold online as DSIP, delta sleep-inducing peptide, emideltide, sleep peptide, or “research use only” DSIP may carry safety, quality, legal, and regulatory risks.
Quick answer
DSIP, short for delta sleep-inducing peptide, is a 9-amino-acid peptide also known as emideltide. Its amino acid sequence is usually listed as Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. DSIP was originally studied because it appeared to induce delta-wave sleep activity in animals and humans. Older human studies reported possible improvements in sleep efficiency, sleep latency, and insomnia symptoms, but the evidence is limited, inconsistent, and not strong enough to make DSIP an approved sleep treatment. DSIP is not FDA-approved, its receptor and natural biological role remain unresolved, and online DSIP products should be treated as unapproved research-use peptides rather than legitimate sleep medicines.
Key facts about DSIP
| Question | Answer |
|---|---|
| What is DSIP? | A 9-amino-acid peptide studied for sleep and neuroendocrine effects. |
| Other names | Delta sleep-inducing peptide, delta-sleep-inducing peptide, emideltide, DSIP acetate. |
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. |
| Peptide class | Sleep-related neuropeptide / investigational nonapeptide / neuroendocrine research peptide. |
| Main mechanism | Unresolved. Proposed effects include delta-wave sleep modulation, neuroendocrine signaling, stress-response modulation, pain modulation, and central nervous system effects. |
| FDA-approved? | No. DSIP is not an FDA-approved drug. |
| Main studied uses | Insomnia, sleep quality, sleep architecture, stress response, pain, withdrawal states, and neuroendocrine regulation. |
| Human evidence level | Limited and old human evidence with mixed findings; not enough for FDA-approved insomnia or sleep-treatment claims. |
| Animal/lab evidence level | Moderate historical animal and mechanistic evidence for sleep-related and neuroendocrine effects, but biological identity remains controversial. |
| Common online claims | “Sleep peptide,” “deep sleep peptide,” “recovery peptide,” “stress peptide,” “anti-aging peptide,” “cortisol peptide,” “withdrawal support peptide.” |
| Sports status | Not found here as specifically named on the WADA prohibited list; athletes should verify current WADA/Global DRO status before use. |
| Main safety concern | Lack of modern human safety data, unresolved mechanism, route-specific uncertainty, product-quality risks, and overstatement of old sleep studies. |
What is DSIP?
DSIP stands for delta sleep-inducing peptide. It is a nonapeptide, meaning it contains nine amino acids.
DSIP is also known as emideltide. The FDA/NCATS Global Substance Registration System lists emideltide as a synonym for delta sleep-inducing peptide and DSIP.
The usual DSIP sequence is:
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
DSIP was originally isolated from rabbit cerebral venous blood during sleep-related experiments and became known because it appeared to induce delta EEG activity and sleep-like changes in experimental animals.
A PubMed review describes DSIP as a nonapeptide with a molecular weight around 849 that was reported to induce mainly delta sleep in rabbits, rats, mice, and humans.
The key distinction:
DSIP is a real historical sleep-research peptide, but it is not an FDA-approved sleep medication and its biological role remains controversial.
How does DSIP work?
DSIP’s mechanism is not settled.
Research has proposed possible effects on:
- Delta-wave sleep activity
- Sleep onset
- Sleep maintenance
- Stress response
- Corticotropin and other neuroendocrine signals
- Pain perception
- Withdrawal states
- Circadian and sleep-wake regulation
- Central nervous system modulation
But DSIP is unusual because its receptor, precursor, and endogenous biological pathway have not been clearly established.
A PubMed mini-review called DSIP a “still unresolved riddle” and discussed uncertainty around DSIP-like immunoreactivity and DSIP-like peptide biology.
In plain English:
DSIP may influence sleep-related and stress-related signaling, but scientists still do not have a clean, modern, receptor-level explanation for what DSIP is doing in humans.
That matters because mechanism uncertainty weakens online claims.
A possible effect on sleep architecture does not prove that DSIP treats insomnia, fixes deep sleep, improves recovery, lowers cortisol, reverses aging, treats addiction, or safely improves performance.
What is DSIP used for?
DSIP is commonly discussed for insomnia, deep sleep, stress, pain, recovery, addiction or withdrawal support, and anti-aging. These uses differ sharply in evidence quality.
| Use | Evidence level | What is known | What is not known | |---|---|---| | Insomnia | Limited old human evidence | Some older studies reported improved sleep efficiency, sleep latency, or insomnia symptoms. | Evidence is too limited and inconsistent for approval-level insomnia claims. | | Sleep quality | Limited old human evidence | A chronic insomnia study reported DSIP improved some objective sleep-quality measures versus placebo. | Effects were weak and may partly reflect placebo-group changes. | | Delta sleep / deep sleep | Historical animal and human evidence | DSIP was named for delta-sleep-related EEG effects. | Reliable deep-sleep enhancement in modern controlled trials is not established. | | Stress response | Mechanistic / weak | DSIP has been studied in neuroendocrine and stress contexts. | Human clinical stress-treatment benefit is not established. | | Pain | Limited early human evidence | Small studies evaluated DSIP in chronic pain contexts. | Not approved as an analgesic and not supported by modern robust pain trials. | | Withdrawal or addiction support | Weak / historical | Older research discussed DSIP in withdrawal and dependence contexts. | It is not an approved addiction or withdrawal treatment. | | Anti-aging / longevity | Unsupported | Some animal and speculative literature exists. | No strong human longevity evidence supports DSIP. | | Athletic recovery | Unsupported | Online claims often connect sleep and recovery. | No strong evidence proves performance or recovery benefit, and product risk remains. | | Online research-use DSIP | High uncertainty | Sold as injectable, nasal, and other products. | Quality, sterility, identity, concentration, absorption, and safety may be unknown. |
What does the research show?
Human evidence for sleep
DSIP has some human sleep research, but it is old and limited.
A PubMed study in chronic insomnia reported higher sleep efficiency and shorter sleep latency with DSIP compared with placebo. The same abstract also cautioned that statistically significant effects were weak and partly could be due to incidental change in the placebo group.
An open clinical trial treated seven patients with severe insomnia using a series of DSIP injections and reported normalization of sleep in most patients for follow-up periods of three to seven months. However, open-label data from seven patients is not strong proof.
A PubMed study on acute and delayed DSIP effects reported that DSIP was well tolerated and suggested effects on natural sleep functions, but the study is old and not enough for modern approval-level conclusions.
The practical interpretation:
DSIP has real historical human sleep research, but it is too limited, too old, and too inconsistent to support strong modern sleep-treatment claims.
Review-level evidence
Older reviews summarize DSIP as a peptide with broad claimed physiological effects.
A 1984 PubMed review described DSIP’s discovery, delta-sleep effects, and multiple proposed physiological activities. A later 1986 update reviewed additional work and ongoing uncertainty.
A 2006 PubMed mini-review emphasized that DSIP remains unresolved and proposed that DSIP-like immunoreactivity may involve DSIP-like peptides rather than a clean, fully characterized endogenous DSIP system.
The practical interpretation:
DSIP is scientifically interesting but messy. The literature is not clean enough to justify the certainty seen in many peptide-vendor claims.
Pain and other clinical research
DSIP has also been studied outside sleep.
A PubMed study in chronic pain reported that DSIP lowered pain levels in six of seven patients after intravenous administration. This is interesting, but extremely small and not enough to establish DSIP as a pain therapy.
The practical interpretation:
Small early clinical studies can generate hypotheses. They do not create an approved treatment.
FDA and regulatory context
DSIP is not FDA-approved.
The FDA/NCATS substance system lists DSIP under the name emideltide, including synonyms such as delta sleep-inducing peptide and DSIP. A substance listing is not the same as drug approval.
The FDA/NCATS G-SRS entry for emideltide identifies the substance and synonyms, but it does not mean DSIP is approved as a medication.
The practical interpretation:
DSIP being listed as a named substance does not mean DSIP is FDA-approved, clinically proven, or safe for consumer use.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “DSIP is delta sleep-inducing peptide.” | Supported | DSIP is the abbreviation for delta sleep-inducing peptide. |
| “DSIP is also called emideltide.” | Supported | FDA/NCATS substance records list emideltide as a synonym. |
| “DSIP is a 9-amino-acid peptide.” | Supported | DSIP is a nonapeptide. |
| “DSIP improves insomnia.” | Limited | Older studies suggest possible effects, but evidence is weak and not approval-level. |
| “DSIP improves deep sleep.” | Not established | Delta-sleep effects are historically reported, but reliable modern clinical proof is lacking. |
| “DSIP treats chronic pain.” | Not established | Small early studies exist, but it is not an approved pain medication. |
| “DSIP treats addiction or withdrawal.” | Not established | Historical interest exists, but clinical proof is inadequate. |
| “DSIP is FDA-approved.” | False | DSIP is not FDA-approved. |
| “DSIP is a safe sleep medicine.” | Unsupported | Long-term safety, route-specific safety, and product quality are not established. |
| “Research-use DSIP is clinically proven.” | False | Research-use products are not FDA-approved consumer therapeutic products. |
| “DSIP is banned in sports.” | Not specifically found here | It was not found here as specifically named on WADA’s prohibited list, but athletes should verify. |
Is DSIP FDA-approved?
No. DSIP is not FDA-approved.
There is no FDA-approved DSIP product for insomnia, deep sleep, sleep quality, stress, pain, withdrawal, recovery, anti-aging, or any other therapeutic use.
The FDA/NCATS substance registry recognizes emideltide/DSIP as a named substance, but a substance record is not drug approval.
The key distinction:
DSIP is an investigational sleep-related peptide, not an FDA-approved prescription sleep aid.
Is DSIP legal?
DSIP’s legal status depends on product type, route, jurisdiction, intended use, and how it is sold.
The practical answer is simple:
DSIP is not an FDA-approved drug, and online availability does not mean it is legally marketed for human therapeutic use.
Some sellers market DSIP as a research peptide, nasal sleep peptide, injectable sleep peptide, recovery peptide, or anti-aging peptide. That does not make it safe, approved, legal, or appropriate for consumer use.
The blunt version:
Buying “research use only” DSIP online is not the same as receiving an FDA-approved sleep medication from a legitimate pharmacy.
Is DSIP banned in sports?
I did not find DSIP specifically named on the WADA prohibited list in the sources reviewed here.
However, athletes should be careful for several reasons:
- Peptide products can be contaminated or mislabeled.
- Anti-doping status can change.
- Unapproved pharmacologic substances can create risk depending on classification, route, or accompanying ingredients.
- Online peptide products may contain substances other than what is listed on the label.
The WADA Prohibited List and USADA prohibited-list guidance should be checked directly before use.
The practical advice:
Athletes should verify DSIP through Global DRO, WADA, or USADA before using it and should avoid unapproved online peptide products.
Safety and side effects
DSIP should not be treated as risk-free.
Possible or theoretical concerns include:
- Headache
- Dizziness
- Nausea
- Fatigue
- Daytime sleepiness
- Sleep-architecture changes
- Mood changes
- Neuroendocrine effects
- Unknown long-term safety
- Unknown route-specific safety
- Unknown interaction risk with sedatives, sleep medications, psychiatric drugs, alcohol, opioids, or other CNS-active substances
- Product-quality and sterility risks from online sources
- Mislabeling or incorrect concentration
- Contamination risk
- Unknown absorption and exposure depending on formulation
The main safety problem is uncertainty.
DSIP is often marketed as a sleep peptide, but there is no FDA-approved label, modern dosing standard, long-term safety database, or consumer-product quality framework.
A serious evaluation of DSIP should separate controlled research from online peptide-market claims.
DSIP vs similar sleep drugs and peptides
| Compound | Category | Main difference |
|---|---|---|
| DSIP | Sleep-related neuropeptide | Investigational nonapeptide studied for sleep and neuroendocrine effects; not FDA-approved. |
| Melatonin | Endogenous hormone / supplement | Regulates circadian timing; not the same as DSIP. |
| Orexin antagonists | Prescription sleep drugs | FDA-approved examples exist for insomnia; different mechanism. |
| Benzodiazepines | Prescription sedatives | FDA-approved examples exist, but with dependence, sedation, and withdrawal risks. |
| Z-drugs | Prescription hypnotics | FDA-approved insomnia drugs; different mechanism and risk profile. |
| GABA supplements | Supplements | Not comparable to DSIP pharmacology or prescription sleep drugs. |
| Selank | Tuftsin-related neuropeptide | Studied more for anxiety and stress, not primarily sleep induction. |
| Semax | ACTH-derived neuropeptide | Studied more for cognition and neuroprotection, not sleep induction. |
The key distinction:
DSIP belongs in the investigational sleep-related neuropeptide category. It is not melatonin, not a benzodiazepine, not an FDA-approved hypnotic, and not a proven sleep supplement.
Why is DSIP sold as “research use only”?
Some online sellers use “research use only” language to sell DSIP outside normal drug channels.
That label is not a trust signal.
A serious reader should understand this distinction:
| Product type | What it means |
|---|---|
| Laboratory DSIP | Research peptide used in controlled experimental settings. |
| FDA-approved DSIP | Does not currently exist. |
| Research-use DSIP | Not an FDA-approved consumer therapeutic product. |
| Online nasal/injectable DSIP | Higher risk for identity, purity, sterility, concentration, absorption, and safety problems. |
How to evaluate DSIP claims online
| Claim | What to verify |
|---|---|
| “FDA-approved DSIP” | False. DSIP is not FDA-approved. |
| “Clinically proven sleep peptide” | Look for modern controlled human trials, not only small older studies. |
| “Deep sleep guaranteed” | Unsupported. DSIP’s sleep effects are inconsistent and not proven for routine use. |
| “Replaces sleep medication” | False. DSIP is not an approved insomnia treatment. |
| “Lowers cortisol” | Check whether evidence is human clinical outcome data or mechanistic speculation. |
| “Recovery peptide” | Marketing claim unless supported by controlled human recovery studies. |
| “Anti-aging peptide” | Unsupported by strong human longevity or healthspan evidence. |
| “No side effects” | Unsupported. Long-term human safety is not established. |
| “Research use only” | This does not mean safe, legal, approved, or appropriate for human use. |
| “Safe for athletes” | Verify through WADA, USADA, or Global DRO before use. |
| “Third-party tested” | Ask for batch-specific HPLC, LC-MS, identity, purity, sterility, endotoxin, microbial, and stability data. |
Bottom line
DSIP is a 9-amino-acid peptide, also called delta sleep-inducing peptide or emideltide, that has been studied for sleep, insomnia, stress, pain, and neuroendocrine effects. The best-known evidence is old and mixed, with some small human studies suggesting possible sleep benefits and other reviews emphasizing unresolved biology.
The most defensible conclusion is:
DSIP is a historically interesting sleep-research peptide, not a proven consumer sleep therapy. It is not FDA-approved, its mechanism remains unresolved, and online DSIP products should be treated as unapproved research-use peptides with uncertain identity, purity, sterility, dosing, and safety.
FAQ
What is DSIP?
DSIP stands for delta sleep-inducing peptide. It is a 9-amino-acid peptide also known as emideltide.
What does DSIP stand for?
DSIP stands for delta sleep-inducing peptide.
What is DSIP’s amino acid sequence?
DSIP is usually listed as Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.
Is DSIP FDA-approved?
No. DSIP is not FDA-approved for insomnia, sleep quality, stress, pain, recovery, anti-aging, or any other therapeutic use.
Does DSIP help with sleep?
Older human studies suggest DSIP may improve some sleep measures, such as sleep efficiency or sleep latency, but the evidence is limited, old, and mixed. DSIP is not an approved insomnia treatment.
Does DSIP increase deep sleep?
DSIP was named for delta-sleep-related effects, but reliable modern clinical evidence for deep-sleep enhancement is lacking.
Is DSIP the same as melatonin?
No. Melatonin is a hormone involved in circadian timing. DSIP is an investigational sleep-related peptide with a different and unresolved mechanism.
Is DSIP safe?
DSIP does not have enough modern long-term human safety data to call it safe for consumer use. Online products also create identity, purity, sterility, concentration, and contamination risks.
Is DSIP legal?
DSIP is not an FDA-approved drug. Online sales as a research peptide do not mean it is legally marketed for human therapeutic use.
Is DSIP banned in sports?
I did not find DSIP specifically named on the WADA prohibited list in the sources reviewed here. Athletes should verify current status with WADA, USADA, or Global DRO before use.
Why do sellers call DSIP “research use only”?
Sellers often use “research use only” language because DSIP is not FDA-approved for consumer therapeutic use. The phrase does not make the product safe, legal, approved, or clinically proven.
What is the biggest risk with DSIP?
The biggest risks are using an unapproved CNS-active peptide without adequate safety data, relying on old and mixed sleep studies, and buying online products with uncertain identity, purity, sterility, concentration, and safety.
Sources
- FDA/NCATS: Emideltide, Delta Sleep-Inducing Peptide, DSIP
- NCATS Inxight Drugs: Emideltide
- PubChem: Delta Sleep-Inducing Peptide
- PubMed: Delta-sleep-inducing peptide, DSIP, a review
- PubMed: Delta-sleep-inducing peptide, DSIP, an update
- PubMed: Delta sleep-inducing peptide, DSIP, a still unresolved riddle
- PubMed: Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients
- PubMed: A clinical trial with DSIP
- PubMed: Acute and delayed effects of DSIP
- PubMed: DSIP, a tool for investigating the sleep onset mechanism
- PubMed: Therapeutic effects of delta-sleep-inducing peptide in chronic pain
- PMC: Pichia pastoris secreted peptides crossing the blood-brain barrier, DSIP discussion
- WADA: Prohibited List
- WADA: 2026 Prohibited List
- USADA: WADA Prohibited List Guidance
Frequently asked questions
What is DSIP?
DSIP stands for delta sleep-inducing peptide. It is a 9-amino-acid peptide also known as emideltide.
What does DSIP stand for?
DSIP stands for delta sleep-inducing peptide.
What is DSIP’s amino acid sequence?
DSIP is usually listed as Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.
Is DSIP FDA-approved?
No. DSIP is not FDA-approved for insomnia, sleep quality, stress, pain, recovery, anti-aging, or any other therapeutic use.
Does DSIP help with sleep?
Older human studies suggest DSIP may improve some sleep measures, such as sleep efficiency or sleep latency, but the evidence is limited, old, and mixed. DSIP is not an approved insomnia treatment.
Does DSIP increase deep sleep?
DSIP was named for delta-sleep-related effects, but reliable modern clinical evidence for deep-sleep enhancement is lacking.
Is DSIP the same as melatonin?
No. Melatonin is a hormone involved in circadian timing. DSIP is an investigational sleep-related peptide with a different and unresolved mechanism.
Is DSIP safe?
DSIP does not have enough modern long-term human safety data to call it safe for consumer use. Online products also create identity, purity, sterility, concentration, and contamination risks.
Is DSIP banned in sports?
No official WADA source was found here specifically naming DSIP as prohibited. Athletes should verify current status with WADA, USADA, or Global DRO before use.
Sources
- [1]FDA/NCATS: Emideltide, Delta Sleep-Inducing Peptide, DSIP
Substance Registry
- [2]NCATS Inxight Drugs: Emideltide
Substance Registry
- [3]PubChem: Delta Sleep-Inducing Peptide
Substance Reference
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]WADA: Prohibited List
Anti Doping
- [14]WADA: 2026 Prohibited List
Anti Doping
- [15]USADA: WADA Prohibited List Guidance
Anti Doping
Last updated May 9, 2026